학술논문
LBA56 MEDI5752 or pembrolizumab (P) plus carboplatin/pemetrexed (CP) in treatment-naïve (1L) non-small cell lung cancer (NSCLC): A phase Ib/II trial
Document Type
Abstract
Author
Source
In Annals of Oncology September 2022 33 Supplement 7:S1423-S1423
Subject
Language
ISSN
0923-7534